We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

195 hedge funds and large institutions have $1.51B invested in Olema Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 51 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

272% more call options, than puts

Call options by funds: $41.3M | Put options by funds: $11.1M

43% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 51

8% less first-time investments, than exits

New positions opened: 46 | Existing positions closed: 50

3% less funds holding

Funds holding: 200 → 195 (-5)

15.73% less ownership

Funds ownership: 132.15% → 116.42% (-16%)

33% less capital invested

Capital invested by funds: $2.27B → $1.51B (-$755M)

73% less funds holding in top 10

Funds holding in top 10: 11 → 3 (-8)

Holders
195
Holders Change
-5
Holders Change %
-2.5%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-72.73%
% of All Funds
0.04%
New
46
Increased
73
Reduced
51
Closed
50
Calls
$41.3M
Puts
$11.1M
Net Calls
+$30.2M
Net Calls Change
+$16.9M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$119M
2
State Street
State Street
Massachusetts
+$45.7M
3
SL
Siren LLC
Connecticut
+$32.4M
4
CAM
Cormorant Asset Management
Massachusetts
+$25.6M
5
DFO
Duquesne Family Office
New York
+$22M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$28M
2
VPC
Vestal Point Capital
New York
-$27.2M
3
SC
Samlyn Capital
New York
-$26.7M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$23M
5
EAM
Eventide Asset Management
Massachusetts
-$14.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
226
Cetera Investment Advisers
Illinois
– -$263K -10,500 Closed
BAM
227
Blueshift Asset Management
New Jersey
– -$256K -10,237 Closed
EWA
228
EP Wealth Advisors
California
– -$250K -10,009 Closed
OC
229
Oppenheimer & Co
New York
– -$238K -9,500 Closed
PAP
230
Persistent Asset Partners
Hong Kong
– -$202K -9,069 Closed
State Board of Administration of Florida Retirement System
231
State Board of Administration of Florida Retirement System
Florida
– -$222K -8,880 Closed
SEI Investments
232
SEI Investments
Pennsylvania
– -$206K -8,259 Closed
QT
233
Quantbot Technologies
New York
– -$201K -8,046 Closed
QL
234
Quarry LP
New York
– -$75K -3,001 Closed
AB
235
Amalgamated Bank
New York
– -$47K -1,871 Closed
TM
236
Torren Management
California
– -$44K -1,759 Closed
A
237
AlphaQuest
New York
– -$42.3K -1,690 Closed
AAP
238
Arax Advisory Partners
Colorado
– -$14.1K -564 Closed
SPIA
239
Steward Partners Investment Advisory
New York
– -$9K -360 Closed
Daiwa Securities Group
240
Daiwa Securities Group
Japan
– -$6K -224 Closed
GWM
241
Greenline Wealth Management
Florida
– -$2.77K -111 Closed
AEPWM
242
Atlantic Edge Private Wealth Management
Florida
– -$1.25K -50 Closed
HBW
243
Hazlett, Burt & Watson
West Virginia
– -$1K -50 Closed
C
244
Covestor
United Kingdom
– -$245 -11 -69%
HFS
245
Hughes Financial Services
Virginia
– -$25 -1 Closed
6 7 8 9
10

OLMA Hedge Fund Activity: Q1 2026 in Review

195 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2026, worth a combined $1.51B — down 33% from $2.27B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of OLMA and 46 opened new positions — a net loss of 4 holders — while 51 trimmed existing stakes and 73 added.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Franklin Resources, cutting an estimated $28M.

  • 195 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2026, down from 200 in Q4 2025.
  • Funds reported $1.51B of Olema Pharmaceuticals stock for Q1 2026, down 33% quarter-over-quarter.
  • 46 funds opened new Olema Pharmaceuticals positions in Q1 2026 and 50 closed out, a net change of -4 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $119M added.
  • The largest Olema Pharmaceuticals seller in Q1 2026 was Franklin Resources, an estimated $28M sold.

Based on aggregated 13F filings for Q1 2026.